Sparsentan for Focal Segmental Glomerulosclerosis
Medpage Today, May 19, 2025
UTMB’s Dr. Shikha Wadhwani joined other experts to discuss the shift toward proteinuria-based endpoints that could finally bring a targeted drug to FSGS patients.
Sparsentan for Focal Segmental Glomerulosclerosis
Medpage Today, May 19, 2025
UTMB’s Dr. Shikha Wadhwani joined other experts to discuss the shift toward proteinuria-based endpoints that could finally bring a targeted drug to FSGS patients.